Alzheimer's disease (AD),characterized by progressive memory impairment and dementia leading to severe deterioration of daily living,has been a public health crisis that currently lacks effective treatments.The re...Alzheimer's disease (AD),characterized by progressive memory impairment and dementia leading to severe deterioration of daily living,has been a public health crisis that currently lacks effective treatments.The reported prevalence of AD was 3.21% in people aged ≥65 years,More than 7 million people live with AD in China today and the number continues to increase.AD imposes a heavy financial burden on the society and it is becoming worse.The total socioeconomic costs of Chinese patients with AD was estimated to be US $167.74 billion in 2015 and is predicted to reach US $1.89 trillion by 2050.展开更多
Anumber of therapies have been developed in the past decades.About two thirds of patients can be seizure free with antiepileptic drugs.1 Other patients are drug resistant,some of whom are good candidates for epileptic...Anumber of therapies have been developed in the past decades.About two thirds of patients can be seizure free with antiepileptic drugs.1 Other patients are drug resistant,some of whom are good candidates for epileptic focus resection and become seizure free after surgery.2 The treatment for drug-resistant patients who are not eligible for resection is still challenging.Traditionally,these patients can receive palliative surgery such as callosotomy and multiple subpial transection,3,4 but the long-term outcomes of these procedures are not satisfactory.5-7 In the past decades,neuromodulation techniques have been applied in the treatment of epilepsy.Much evidence has been accumulated about the therapeutic effects of vagus nerve stimulation for epilepsy.In contrast to peripheral nerve stimulation,brain stimulation techniques have also been developed for patients with epilepsy recently.展开更多
文摘Alzheimer's disease (AD),characterized by progressive memory impairment and dementia leading to severe deterioration of daily living,has been a public health crisis that currently lacks effective treatments.The reported prevalence of AD was 3.21% in people aged ≥65 years,More than 7 million people live with AD in China today and the number continues to increase.AD imposes a heavy financial burden on the society and it is becoming worse.The total socioeconomic costs of Chinese patients with AD was estimated to be US $167.74 billion in 2015 and is predicted to reach US $1.89 trillion by 2050.
文摘Anumber of therapies have been developed in the past decades.About two thirds of patients can be seizure free with antiepileptic drugs.1 Other patients are drug resistant,some of whom are good candidates for epileptic focus resection and become seizure free after surgery.2 The treatment for drug-resistant patients who are not eligible for resection is still challenging.Traditionally,these patients can receive palliative surgery such as callosotomy and multiple subpial transection,3,4 but the long-term outcomes of these procedures are not satisfactory.5-7 In the past decades,neuromodulation techniques have been applied in the treatment of epilepsy.Much evidence has been accumulated about the therapeutic effects of vagus nerve stimulation for epilepsy.In contrast to peripheral nerve stimulation,brain stimulation techniques have also been developed for patients with epilepsy recently.
